Our analysis of the methylation levels of LMX1A, SOX1, and ZN177 in CRC revealed that the combination of the methylation statuses of NKX6.1, LMX1A, SOX1, and ZNF177 was an independent indicator of the outcomes of CRC patients. This evidence concerns the gene NKX6-1 and colorectal carcinoma.